Article

Primary Cutaneous T-Cell–Rich B-Cell Lymphoma: Clinically Distinct from Its Nodal Counterpart?

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
Modern Pathology (Impact Factor: 6.36). 02/2001; 14(1):10-3. DOI: 10.1038/modpathol.3880250
Source: PubMed

ABSTRACT The cases of two patients with Stage IE primary cutaneous T-cell-rich B-cell lymphoma (TCRBCL) are described. In both, the lesion showed a dense infiltrate by numerous small T lymphocytes with scattered histiocytes and large atypical B-lymphoid cells. Polymerase chain reaction assays demonstrated that the B cells were monoclonal, with immunoglobulin heavy-chain gene rearrangement. No clonal rearrangements of the T-cell receptor gamma gene were observed. Both patients were disease-free at 4 months and at 5 years after therapy, respectively. Although rare, primary cutaneous T-cell-rich B-cell lymphoma appears to have a better prognosis than its nodal counterpart, with or without skin involvement.

Full-text

Available from: Shiyong Li, Apr 17, 2014
0 Followers
 · 
69 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Esta guía fue comisionada por la SAD para consensuar las formas clínicas de presentación, los procedimientos de diagnóstico, y las modalidades terapéuticas en los Linfomas Cutáneos Primarios (LCP). A tal efecto hemos acordado seguir la clasificación propuesta por la WHO/EORTC 2005. EPIDEMIOLOGÍA La incidencia de los LCP en nuestro país es desconocida. La incidencia en Europa es de 0-4/100.000/año. La mayoría son linfomas de bajo grado con buen pronóstico. La piel es asiento del 30% de todos los linfomas primarios extraganglionares. Su incidencia anual estimada es de 1 por 100.000 habitantes. Dos tercios de los LCP son Linfomas Cutáneos a Células T (CTCL) y la mayoría de estos son Micosis Fungoide (MF). Cuando después de una estadificación adecuada no hallamos manifestaciones en otro órgano, podemos decir que estamos frente a un linfoma primario cutáneo. A diferencia de los linfomas ganglionares: 1) En la piel el 65% de los linfomas son T y sólo el 25% son B. 2) Los linfomas cutáneos T se desarrollan en un proceso de múltiples pasos. 3) El linfoma cutáneo más frecuente, la MF, es exclusivo de la piel. 4) A pesar de su similitud morfológica, algunos linfomas cutáneos de células grandes tienen un pronóstico muy distinto al de sus equivalentes ganglionares. El manejo de los LCP, con excepción de la MF en estadios tempranos y la Papulosis linfomatoide (LyP), requiere un equipo multidisciplinario que debe incluir dermatólogo, anatomopatólogo y hematooncólogo con considerable experiencia en el diagnóstico y manejo de los mismos. En algunas situaciones hay que considerar la revisión de los casos por centros especializados.
  • [Show abstract] [Hide abstract]
    ABSTRACT: T-cell/histiocyte-rich diffuse large B-cell lymphoma is characterized by abundant reactive T-cell and histiocyte infiltration within nodal diffuse large B-cell lymphoma, and only limited cases of primary cutaneous T-cell-rich B-cell lymphoma have been documented. These reactive T-cells usually show a T-helper phenotype. Gamma/delta T-cell is a functionally distinct T-cell lineage, which constitutes on average 5% of all T-cells in the peripheral blood. Herein, we report the first documented case of primary cutaneous malignant B-cell lymphoma with abundant reactive gamma/delta(+) T-cells within the skin lesion and peripheral blood. An 80-year-old Japanese male presented with a gradually enlarged knee nodule. Histopathological study revealed diffuse infiltration of lymphoid cells in the dermis and subcutis. Proliferation of large-sized atypical lymphoid cells was observed among medium-sized lymphocytes with convoluted nuclei. Immunohistochemically, these large-sized atypical lymphocytes were CD20(+), and relatively many gamma/delta(+) cell infiltration was also noted. Flowcytometric analysis revealed deviation of lambda+ cells (lambda/kappa 58) and increase of CD3(+) gamma/delta(+) cells (6%). Peripheral blood had CD3(+) gamma/delta(+) cells (28.8%). Rearrangement of immunoglobulin heavy chain, but not of T-cell receptor beta and gamma chains, was observed. Accordingly, an ultimate diagnosis of cutaneous B-cell lymphoma with abundant reactive gamma/delta(+) cells was made. Recent studies have shown reactive gamma/delta(+) T-cell infiltration and/or elevation in the peripheral blood in patients with various types of carcinoma, and that they play a role in the pathogenesis of some carcinomas. Therefore, additional analysis is needed to clarify the role of reactive gamma/delta(+) T-cells in malignant lymphoma.
    International journal of clinical and experimental pathology 01/2014; 7(3):1193-9. · 1.78 Impact Factor
  • Source